Want to join the conversation?
$ALXN's net product sales for FY15 grew by 17% from last year. The increase was primarily due to rise in unit volumes of 29% due to increased demand globally for Soliris therapy for patients with PNH or aHUS during the respective periods. The positive impact of volume on net product sales was offset by negative impact on foreign exchange of 8%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?